Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma

Author:

Dong Xuesi12,Zhang Ruyang2345,He Jieyu2,Lai Linjing2,Alolga Raphael N.6,Shen Sipeng234,Zhu Ying2,You Dongfang2,Lin Lijuan2,Chen Chao2,Zhao Yang2,Duan Weiwei2,Su Li34,Shafer Andrea7,Salama Moran8,Fleischer Thomas9,Bjaanæs Maria Moksnes9,Karlsson Anna10,Planck Maria10,Wang Rui5,Staaf Johan10,Helland Åslaug911,Esteller Manel8,Wei Yongyue234,Chen Feng12412,Christiani David C.347

Affiliation:

1. Department of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing 210009, China

2. Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China

3. Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA

4. China International Cooperation Center for Environment and Human Health, Nanjing Medical University, Nanjing 211166, China

5. Department of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing 210002, China

6. Clinical Metabolomics Center, China Pharmaceutical University, Nanjing 211198, China

7. Pulmonary and Critical Care Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA

8. Bellvitge Biomedical Research Institute and University of Barcelona, Institucio Catalana de Recerca i Estudis Avançats, Barcelona 08908, Catalonia , Spain

9. Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo 0424, Norway

10. Division of Oncology and Pathology, Department of Clinical Sciences Lund, CREATE Health Strategic Center for Translational Cancer Research, Lund University, Lund 2238, Skåne, Sweden

11. Institute of Clinical Medicine, University of Oslo, Oslo 0424, Norway

12. Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Ageing

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3